1. Risk factors for fatty pancreas and effects of fatty infiltration on pancreatic cancer
   Nao Otsuka et al, 2023, Frontiers in Physiology CrossRef
2. Association of NQO1Pro187Ser Polymorphism with Clinical Outcomes and Survival of Lung Cancer Patients Treated with Platinum Chemotherapy
   Harleen Kaur Walia et al, 2021, Personalized Medicine CrossRef
3. Integrated Analyses Identify Immune-Related Signature Associated with Qingyihuaji Formula for Treatment of Pancreatic Ductal Adenocarcinoma Using Network Pharmacology and Weighted Gene Co-Expression Network
   Xiang Qian et al, 2020, Journal of Immunology Research CrossRef
4. A novel strategy for glioblastoma treatment by induction of noptosis, an NQO1-dependent necrosis
   Bingling Zhong et al, 2021, Free Radical Biology and Medicine CrossRef
5. Napabucasin plus nab-paclitaxel with gemcitabine versus nab-paclitaxel with gemcitabine in previously untreated metastatic pancreatic adenocarcinoma: an adaptive multicentre, randomised, open-label, phase 3, superiority trial
   Tanios Bekaii-Saab et al, 2023, eClinicalMedicine CrossRef
6. Polyurethane Foam Rafts Supported In Vitro Cultures of Rindera graeca Roots for Enhanced Production of Rinderol, Potent Proapoptotic Naphthoquinone Compound
   Mateusz Kawka et al, 2021, International Journal of Molecular Sciences CrossRef
7. Novel β‐carboline‐based indole‐4,7‐quinone derivatives as NAD(P)H: Quinone‐oxidoreductase‐1 inhibitor with potent antitumor activities by inducing reactive oxygen species, apoptosis, and DNA damage
   Yibing Guo et al, 2020, Chemical Biology & Drug Design CrossRef
8. PRDX5 as a novel binding partner in Nrf2-mediated NSCLC progression under oxidative stress
   Xinming Chen et al, 2020, Aging CrossRef
9. A caged metabolic precursor for DT-diaphorase-responsive cell labeling
   Ruibo Wang et al, 2018, Chemical Communications CrossRef
10. Eşzamanlı Kemoradyoterapi ile Tedavi Edilen Evre III Küçük Hücreli Dışı Akciğer Kanserli Hastalarda NQO1’in Prognostik Önemi
    Celalettin EROĞLU et al, 2023, Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi Dergisi CrossRef
11. Regulatory mechanisms of hypoxia‐inducible factor 1 activity: Two decades of knowledge
    Sho Koyasu et al, 2018, Cancer Science CrossRef
12. Quinone oxidoreductase 1 is overexpressed in gastric cancer and associated with outcome of adjuvant chemotherapy and survival
    Zhi-Nong Jiang et al, 2021, World Journal of Gastroenterology CrossRef
13. Discovery of Natural Products Targeting NQO1 via an Approach Combining Network-Based Inference and Identification of Privileged Substructures
    Zengrui Wu et al, 2021, Journal of Chemical Information and Modeling CrossRef
14. Effect of β-Eudesmol on NQO1 suppression-enhanced sensitivity of cholangiocarcinoma cells to chemotherapeutic agents
    Pimradasiri Srijiwangsa et al, 2018, BMC Pharmacology and Toxicology CrossRef
15. Identification of DNA methylation-driven genes and construction of a nomogram to predict overall survival in pancreatic cancer
    G.C Deng et al, 2021, BMC Genomics CrossRef
16. Albumin binding revitalizes NQO1 bioactivatable drugs as novel therapeutics for pancreatic cancer
    Lei Dou et al, 2022, Journal of Controlled Release CrossRef